Literature DB >> 26452110

American Thoracic Society-European Respiratory Society Classification of the Idiopathic Interstitial Pneumonias: Advances in Knowledge since 2002.

Nicola Sverzellati1, David A Lynch1, David M Hansell1, Takeshi Johkoh1, Talmadge E King1, William D Travis1.   

Abstract

In the updated American Thoracic Society-European Respiratory Society classification of the idiopathic interstitial pneumonias (IIPs), the major entities have been preserved and grouped into (a) "chronic fibrosing IIPs" (idiopathic pulmonary fibrosis and idiopathic nonspecific interstitial pneumonia), (b) "smoking-related IIPs" (respiratory bronchiolitis-associated interstitial lung disease and desquamative interstitial pneumonia), (c) "acute or subacute IIPs" (cryptogenic organizing pneumonia and acute interstitial pneumonia), and (d) "rare IIPs" (lymphoid interstitial pneumonia and idiopathic pleuroparenchymal fibroelastosis). Furthermore, it has been acknowledged that a final diagnosis is not always achievable, and the category "unclassifiable IIP" has been proposed. The diagnostic interpretation of the IIPs is often challenging because other diseases with a known etiology (most notably, connective tissue disease and hypersensitivity pneumonitis) may show similar morphologic patterns. Indeed, more emphasis has been given to the integration of clinical, computed tomographic (CT), and pathologic findings for multidisciplinary diagnosis. Typical CT-based morphologic patterns are associated with the IIPs, and radiologists play an important role in diagnosis and characterization. Optimal CT quality and a systematic approach are both pivotal for evaluation of IIP. Interobserver variation for the various patterns encountered in the IIPs is an issue. It is important for radiologists to understand the longitudinal behavior of IIPs at serial CT examinations, especially for providing a framework for cases that are unclassifiable or in which a histologic diagnosis cannot be obtained. (©)RSNA, 2015.

Entities:  

Mesh:

Year:  2015        PMID: 26452110     DOI: 10.1148/rg.2015140334

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  28 in total

1.  HRCT in smoking-related interstitial lung diseases: a kaleidoscopic overlap of patterns.

Authors:  Gaetano Rea; Tullio Valente; Edson Marchiori
Journal:  J Bras Pneumol       Date:  2016-04       Impact factor: 2.624

2.  Magnetic resonance imaging in the evaluation of idiopathic pulmonary fibrosis: a real possibility, or an attractive challenge?

Authors:  Gaetano Rea
Journal:  Quant Imaging Med Surg       Date:  2016-06

Review 3.  Combined pulmonary fibrosis and emphysema (CPFE): what radiologist should know.

Authors:  Federica Ciccarese; Domenico Attinà; Maurizio Zompatori
Journal:  Radiol Med       Date:  2016-02-19       Impact factor: 3.469

4.  Radiographic patterns of symptomatic radiation pneumonitis in lung cancer patients: Imaging predictors for clinical severity and outcome.

Authors:  Richard Thomas; Yu-Hui Chen; Hiroto Hatabu; Raymond H Mak; Mizuki Nishino
Journal:  Lung Cancer       Date:  2020-04-30       Impact factor: 5.705

5.  CT features of diffuse lung disease in infancy.

Authors:  Paolo Toma; Aurelio Secinaro; Oliviero Sacco; Davide Curione; Renato Cutrera; Nicola Ullmann; Claudio Granata
Journal:  Radiol Med       Date:  2018-03-22       Impact factor: 3.469

6.  Radiographic Progression and Survival of the Different HRCT Patterns of Idiopathic Pulmonary Fibrosis.

Authors:  Marco Mura; Carlotta Rellini; Nada Taha; Francesco Paolo Sbordone; Flavia Rufi; Francesca Montesanto; Roberto Floris; Maurizio Zompatori; Gianluigi Sergiacomi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

7.  Effect of Nintedanib in Subgroups of Idiopathic Pulmonary Fibrosis by Diagnostic Criteria.

Authors:  Ganesh Raghu; Athol U Wells; Andrew G Nicholson; Luca Richeldi; Kevin R Flaherty; Florence Le Maulf; Susanne Stowasser; Rozsa Schlenker-Herceg; David M Hansell
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

Review 8.  Imaging of Hypersensitivity Pneumonitis.

Authors:  Andrea L Magee; Steven M Montner; Aliya Husain; Ayodeji Adegunsoye; Rekha Vij; Jonathan H Chung
Journal:  Radiol Clin North Am       Date:  2016-08-11       Impact factor: 2.303

Review 9.  Treatment for systemic sclerosis-associated interstitial lung disease.

Authors:  David Roofeh; Alain Lescoat; Dinesh Khanna
Journal:  Curr Opin Rheumatol       Date:  2021-05-01       Impact factor: 4.941

10.  Progression to fibrosing diffuse alveolar damage in a series of 30 minimally invasive autopsies with COVID-19 pneumonia in Wuhan, China.

Authors:  Yan Li; Junhua Wu; Sihua Wang; Xiang Li; Junjie Zhou; Bo Huang; Danju Luo; Qin Cao; Yajun Chen; Shuo Chen; Lin Ma; Li Peng; Huaxiong Pan; William D Travis; Xiu Nie
Journal:  Histopathology       Date:  2020-11-11       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.